miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver

EMBO J. 2012 Apr 4;31(7):1752-63. doi: 10.1038/emboj.2012.25. Epub 2012 Feb 28.

Abstract

Liver metastasis is a major lethal complication associated with colon cancer, and post-intravasation steps of the metastasis are important for its clinical intervention. In order to identify inhibitory microRNAs (miRNAs) for these steps, we performed 'dropout' screens of a miRNA library in a mouse model of liver metastasis. Functional analyses showed that miR-493 and to a lesser extent miR-493(*) were capable of inhibiting liver metastasis. miR-493 inhibited retention of metastasized cells in liver parenchyma and induced their cell death. IGF1R was identified as a direct target of miR-493, and its inhibition partially phenocopied the anti-metastatic effects. High levels of miR-493 and miR-493(*), but not pri-miR-493, in primary colon cancer were inversely related to the presence of liver metastasis, and attributed to an increase of miR-493 expression during carcinogenesis. We propose that, in a subset of colon cancer, upregulation of miR-493 during carcinogenesis prevents liver metastasis via the induction of cell death of metastasized cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic / metabolism
  • Cell Transformation, Neoplastic / pathology
  • Colonic Neoplasms / pathology*
  • Flurbiprofen / analogs & derivatives
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / secondary*
  • Mice
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Receptor, IGF Type 1 / genetics
  • Receptor, IGF Type 1 / metabolism

Substances

  • MIRN493 microRNA, human
  • MicroRNAs
  • nitroflurbiprofen
  • Flurbiprofen
  • Receptor, IGF Type 1

Associated data

  • GEO/GSE31751